
Russia
We are pausing our operations in Russia for the foreseeable future, this follows our ceasing of supply to the country from the 3 March. We have no manufacturing operations in the country with one sales office - Croda Russia and Iberchem Russia. In 2021 less than 1% of Group sales were to Russia.
As the situation remains complex and is rapidly evolving, we are currently unsure how long our operations in Russia will remain closed, we will keep the situation under review, taking any further actions in line with our company values. We are hopeful that there will be a swift and peaceful resolution to the conflict soon.
Further reading

Launch of Croda Pharma
Corporate23 May 2022: Our Health Care division becomes Croda Pharma
Read more
Croda wins sustainability award at Syngenta Suppliers Awards
Crop Care01 June 2022: Croda has been announced the winner of of the ‘reduction in carbon’ category at the Syngenta Suppliers Awards today, 1st June 2022. At the ceremony, held in Frankfurt, Germany, the...
Read more
UK Government to support expansion of Croda's lipid systems manufacturing facility
Corporate31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.
Read more
Croda celebrates Consumer Care wins
Corporate13 June 2022: Consumer Care wins the 'Innovation' award and the 'Creativity' award
Read more